BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-599@pharmaconomics
DTSTAMP:20260707T015357Z
DTSTART;VALUE=DATE:20260326
DTEND;VALUE=DATE:20260327
SUMMARY:KOD Phase 3 — Zenkuda
DESCRIPTION:Phase 3 trial results for Zenkuda in diabetic retinopathy are due Mar 26\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1468748/000119312526127041/d283186d8k.htm\n\nTrack it: https://pharmaconomics.com/e/599
URL:https://pharmaconomics.com/e/599
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:KOD catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR